EP3110440
And-CD38-mótefni til meðhöndlunar á bráðu eitilfrumuhvítblæði
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
25.2.2015EP published:
23.8.2023EP application number:
15755939.4
EP translation filed:
23.10.2023Grant published:
15.11.2023EPO information:
European Patent Register
Max expiry date:
24.2.2035Expiry date:
24.2.2026Next due date:
28.2.2026
Title in English:
ANTI-CD38 ANTIBODIES FOR TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIALanguage of the patent:
English
Timeline
Today
25.2.2015EP application
23.8.2023EP Publication
23.10.2023Translation submitted
15.11.2023Registration published
24.2.2026Expires
Owner
Name:
Janssen Biotech, Inc.Address:
800/850 Ridgeview Drive, Horsham, PA 19044, US
Inventor
Name:
DOSHI, ParulAddress:
Spring House, Pennsylvania 19477, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201461946008 PDate:
28.2.2014Country:
US
Number:
201462004540 PDate:
29.5.2014Country:
US
Classification
Categories:
C07K 16/28, A61P 35/02, A61P 43/00, A61K 39/00, A61K 31/475
Annual fees
Number
Paid
Expires
Payer
Number: 10
Paid: 9.1.2024
Expires: 24.2.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 16.1.2025
Expires: 24.2.2026
Payer: Árnason Faktor ehf.